Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,187.70 -53.56 (-0.65%) Bitcoin USD
55,648.40 -1,625.50 (-2.84%) CMC Crypto 200
1,153.52 -55.17 (-4.56%)
IRADIMED CORPORATION (IRMD)
| Previous close | 43.98 |
| Open | 43.82 |
| Bid | 43.28 x 200 |
| Ask | 43.88 x 200 |
| Day's range | 43.45 - 43.82 |
| 52-week range | 36.12 - 50.85 |
| Volume | |
| Avg. volume | 48,114 |
| Market cap | 552.41M |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | 31.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.60 (1.36%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Trading to commence effective on the market open June 14, 2024WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Global Market, effective June 14, 2024, and will continue under the ticker symbol “IRMD.” Stockholders are not required to take any action due to the uplistin
- GlobeNewswire
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023.Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024. WINTER SPRINGS, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the
- GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
